4//SEC Filing
GRAHAM RICHARD A 4
Accession 0001415889-23-014680
CIK 0001583107other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:35 PM ET
Size
5.1 KB
Accession
0001415889-23-014680
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Award
Ordinary Shares
2023-10-30+15,000→ 349,321 total
Footnotes (1)
- [F1]On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001820036
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 6:35 PM ET
- Size
- 5.1 KB